n
 
About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Tuesday, October 10th, 2017

The QualityStocks
Daily Stock List

graphic
graphic

Heritage Global, Inc. (HGBL)

TheMicrocapNews and SmallCapVoice reported earlier on Heritage Global, Inc. (HGBL), and we are reporting on the Company today, here at the QualityStocks Daily Newsletter.

Heritage Global, Inc. is a leader in asset liquidation transactions, valuations, and advisory services. The Company concentrates on identifying, valuing, acquiring, and monetizing underlying assets in 28 international manufacturing and technology sectors. Heritage Global’s operating companies are Heritage Equity Partners, Heritage Global Partners, Heritage Global Valuations, Heritage Global Patents & Trademarks, Heritage NLEX, and Heritage Zetabid Realty Services. Heritage Global is based in San Diego, California.

The Company’s goal is to conduct all of its business under its two main platforms: Heritage Global Partners for auctions, valuations, acquisitions and dispositions of surplus assets and plant closures, and Heritage Equity Partners (HEP) for advisory services and disposition services of distressed and non-distressed continuing enterprise sales. Heritage Equity Partners (HEP) is based in Easton, Maryland. HEP provides boutique investment banking services for special situations.

Heritage Global specializes in acting as an adviser and acquiring or brokering turnkey manufacturing facilities, surplus industrial machinery and equipment, industrial inventories, accounts receivable (AR) portfolios and related intellectual property (IP), and whole business enterprises. The Company has completed hundreds of transactions since forming, acting as principal and advisor and member of different syndicates together with distressed and surplus asset industry leaders.

Heritage Global has its Heritage Zetabid Realty Services (HZRS). This is its real estate auction platform and services division. HZRS complements and expands Heritage Global’s existing asset valuation, advisory, and auction capabilities through adding new service offerings and experienced industry professionals to effectively market and monetize clients’ commercial, industrial, and luxury/bank-owned residential real estate assets. Heritage Zetabid Realty Services is a strategic alliance between Heritage Global and Zetabid, a top provider of real estate marketing services.

Recently, Heritage Global Partners (HGP) announced the expansion of its first-rate asset valuation and appraisal services division in the Midwest region. HGP appointed industry veteran Mr. Tim Serritella to Director of Sales. This is to support the continued growth of Heritage Global Valuations (HGV).

Mr. Serritella will be responsible for supervising the new business development and sales initiatives in markets throughout the Midwest. He has greater than two decades of expertise providing financial and management solutions to business owners and senior management teams across a wide array of sectors.

Heritage Global, Inc. (HGBL), closed Tuesday's trading session at $0.54, up 10.20%, on 400 volume with 2 trades. The average volume for the last 60 days is 6,384 and the stock's 52-week low/high is $0.175/$0.77.

Surna, Inc. (SRNA)

Actual Gains, Hot Stock Profits, PennyStockRumors.net, DSR News, PricelessPennyStocks, Value Penny Stocks, Ascending Stocks, Promotion Stock Secrets, Wall Street Mover, TopPennyStockMovers, Marketbeat, CFN Media Group, Cannabis Financial Network News, PHUB News, SmallCapVoice, Greenbackers, OTC Stock Review, and Market Wire Stocks reported on Surna, Inc. (SRNA), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Surna, Inc. develops, acquires, produces, and sells equipment for the legal marijuana industry. The Company develops unique technologies and products to monitor, control, and address the energy and resource intensive nature of indoor cannabis cultivation. Surna’s mission is to acquire intellectual property (IP) and scalable operating companies in the nascent, legal marijuana industry with an emphasis on disruptive technology, equipment, and related support services. The Company’s aim is to dominate the infrastructure, growing, and support side of the worldwide cannabis industry.

Surna has its head office in Boulder, Colorado. The Company is a technology enterprise that engineers, manufactures, and distributes state-of-the art equipment and systems for Controlled Environment Agriculture (CEA). At present, it specializes in commercial indoor cannabis cultivation.

Surna’s business model excludes the production or sale of marijuana. Surna develops cutting-edge technologies and products. The foundation of its current revenue stream is on its chief product offerings - supplying industrial technology and products to commercial indoor cannabis grow facilities. Through its wholly-owned subsidiary, Hydro Innovations, Surna provides a complete line of commercial and small business indoor agriculture equipment.

Surna has its signature water-cooled climate control platform. It has filed a provisional patent application encompassing enhancements to its proprietary Climate Control Systems and Methods used in indoor gardens. The patent covers an industrial process that provides electricity, heating, and cooling while using the resulting carbon-dioxide (CO2) produced as a nutrient for the plants.

The Company’s intention is to integrate this and other proprietary technology into a new, commercial-grade power-generating and environmental control system product. The system is undergoing design to provide a near zero waste energy alternative for the cannabis industry.

Recently, Surna announced the launch of a new website and brand strategy to reflect its increasing position as a go-to solutions provider and the increasing impact its technology is having on the cultivation industry. The Company has become a leader for indoor growth cultivation via its expertise and technology developments in climate control and biosecurity systems.

Brandy Keen, Surna’s Sr. Technical Advisor and Co-Founder will be speaking on the topic of cannabis energy and water conservation solutions that produce greater yield at the following upcoming conferences in October. One is the Sustainability Symposium in Denver, Colorado on October 16th. The other is the CannaGrow Expo in Denver on October 28th.

Surna, Inc. (SRNA), closed Tuesday's trading session at $0.1059, up 1.24%, on 89,071 volume with 37 trades. The average volume for the last 60 days is 376,228 and the stock's 52-week low/high is $0.0912/$0.294.

E-Qure Corp. (EQUR)

AwesomePennyStocks and OTC Markets reported on E-Qure Corp. (EQUR) and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Incorporated in 1988, E-Qure Corp. is a leader in medical devices for the treatment of advanced wound care. The Company focuses on the development and commercialization of Bioelectrical Signal Therapy (BST) devices in the U.S. A management team with comprehensive experience in electrotherapies, medical technologies, wound care, regulatory affairs, and finance leads E-Qure.

E-Qure’s global operations center on managing the processes of design, production, regulation, and distribution of the Company products and services. E-Qure is based in New York City.

The Company’s BST device utilizes patented and proprietary electrical stimulation technologies to treat hard-to-cure wounds and ulcers up to complete closure and/or cure. E-Qure’s BST device reduces treatment and hospitalization time, and lessens the need for surgery and amputation. The BST Device has received regulatory approval in Europe and Israel.

The BST device is a clinically approved non-invasive, painless and user-friendly electrotherapy. The BST device is easily applied by the caregiver or patient in the hospital or clinic setting and in home care.

The BST device can speed up healing with fast wound closure from 45 to 60 days. Through causing wounds to respond to stimulating signals, the BST device increases the body’s naturally occurring electrical currents to stimulate the wound healing process of Diabetic Wounds; Vascular (Arterial or Venous) Leg Ulcers; Pressure (Decubitus) Wounds; and other Ulcers/Wounds that are resistant to standard or more complex treatments.

The BST signal enables the stimulation of sensory nerves and direct stimulation of the ulcer tissues. The nervous system interprets the transmitted pulse from the damaged area. It then begins healing activity to the wound tissues.

E-Qure announced in February 2017 that it received approval from the U.S. Food and Drug Administration (FDA) to conduct its pivotal trial for its patented Bio-electrical Signal Therapy Device (BST Device) in the treatment of chronic wound care as a staged study, potentially shortening the length of the trial. The approval to increase the number of institutions where the first 10 patients can be treated is expected to allow E-Qure to significantly shorten the safety portion of the trial.

This will result in an accelerated timeline to treat all 90 patients planned for inclusion in the study. E-Qure is seeking FDA approval for the device to commence marketing it in the United States.

The BST Device activates a healing process that involves Wound Healing - the initiation and speeding up of the wound healing process; Pain - reduction of local pain and considerable increase in tissue viability. The wound healing process also involves Granulation – the regeneration of viable connective tissue; Epithelialisation –the regeneration of viable epithelial tissue; and Vascularisation (angiogenesis) - the regeneration of vital blood vessels.

E-Qure Corp. (EQUR), closed Tuesday's trading session at $0.0785, even for the day. The average volume for the last 60 days is 10,750 and the stock's 52-week low/high is $0.055/$0.51.

Boston Therapeutics, Inc. (BTHE)

MissionIR, Tiny Gems, FeedBlitz, Wall Street Mover, RedChip, TaglichBrothers, Stock News Now, TopPennyStockMovers, SmallCapVoice, PennyStocks24, and Information Solutions Group reported earlier on Boston Therapeutics, Inc. (BTHE), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Boston Therapeutics, Inc. is a developer of complex carbohydrate therapeutics to treat diabetes and inflammatory diseases. Its product pipeline focuses on developing and commercializing therapeutic molecules that address diabetes and inflammatory diseases. Boston Therapeutics has its headquarters in Lawrence, Massachusetts. The Company’s shares trade on the OTC Markets’ OTCQB.

In addition, Boston Therapeutics developed and markets SUGARDOWN®. This is a non-systemic, complex carbohydrate-based dietary food supplement. The design of SUGARDOWN® is to support healthy blood glucose. SUGARDOWN®, in its current formulation, is a natural sugar blocker dietary supplement product made completely from a non-digestible sugar molecule, which can help people maintain healthier weight levels. It is the first chewable tablet of its kind.

The Company’s product pipeline includes BTI-320. This is a non-systemic, non-toxic, chewable complex carbohydrate-based compound. The design of it is to reduce post-meal glucose elevation. BTI-320 is a proprietary polysaccharide.

BTI-320 works in the gastrointestinal tract to block the action of carbohydrate-hydrolyzing enzymes that break down complex carbohydrates into simple sugars, reducing the availability of glucose for absorption into the bloodstream.

Boston Therapeutics entered a clinical trial agreement with Joslin Diabetes Center to be the lead clinic in a Phase II study of BTI-320. Furthermore, the Company’s product pipeline includes IPOXYN™. This is an injectable anti-necrosis drug. The design of it initially is to treat lower limb ischemia associated with diabetes.

The Company’s product pipeline also includes OXYFEX™. This product can serve as the only available oxygen delivery mechanism for animals suffering ischemia or traumatic and surgical blood loss events. OXYFEX™ is Boston Therapeutics’ veterinary facsimile to IPOXYN™.

Boston Therapeutics announced in 2015 that its affiliate, Advance Pharmaceutical, started the SUGARDOWN® clinical trial in Hong Kong. Advance is evaluating the effect of SUGARDOWN® on Post-Prandial Hyperglycemia in Chinese subjects with Pre-Diabetes. The lead clinical site is the Department of Medicine, The Chinese University of Hong Kong (CUHK), Prince of Wales Hospital.

Advance Pharmaceutical is conducting this clinical trial at CUHK to evaluate BTI-320 in subjects who are pre-diabetic. The interim clinical analysis in the proof of concept trial demonstrates up to 77 percent reduction in Glucose and up to 27 percent in Fructose.

Boston Therapeutics and Advance Pharmaceutical announced in April 2017 the fully funded new trial plans to support the safety and efficacy of BTI-320, commencing with a randomized, placebo-controlled, double-blinded, multi-center, international study on type 2 diabetic (T2D) patients. The study will start as soon as drug supply is processed and will ultimately include 300 T2D patients now on anti-diabetic regimen.

Recruitment will start at the Joslin Diabetes Center, Boston, Massachusetts. It will be joined by its former trial center from the Chinese University of Hong Kong (CUHK) that has also been confirmed. The plans anticipate up to 10 additional institutions from the United States and greater China.

Boston Therapeutics, Inc. (BTHE), closed Tuesday's trading session at $0.0421, even for the day, on 34 volume with 1 trade. The average volume for the last 60 days is 14,528 and the stock's 52-week low/high is $0.03/$0.169.

Innovative Designs, Inc. (IVDN)

Greenbackers, Pennybuster, and PennyStocks24 reported earlier on Innovative Designs, Inc. (IVDN), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Innovative Designs, Inc. manufactures Insultex® House Wrap, the Arctic Armor® Line, hunting apparel, swimwear, wind shirts, jackets, and the multi-function "All in One" under the "IDI Gear" label featuring Insultex®. All of its products contain Insultex®. The Company’s products deliver premier warmth and comfort with insulating, windproof, as well as waterproof protection. Insultex® is the lightest and thinnest thermal insulation. Established in 2002, Innovative Designs is based in Pittsburgh, Pennsylvania.

Since its establishment, Innovative Designs has centered its efforts on completing the development, design, and prototypes of its products, and obtaining retail stores or sales agents to offer and sell its products. The Company primarily sells its products via agencies, distributors, independent sales agents, retailers, and a Website in the United States and Canada.

Additionally, the Company has concentrated its efforts on developing its website to sell more of its products, and on establishing distribution channels for its House Wrap® product.

Arctic Armor™ by IDI Gear is a 100 percent waterproof and windproof breathable nylon shell with Insultex® Thermal Insulation. The Company offers the Arctic Armor™ Suit. Each Arctic Armor™ suit uses three layers of its exclusive thermal insulator Insultex®. Moreover, Innovative Designs offers the Arctic Armor™ Ice Fishing Suit. The Company can also supply national home builders with its Insultex® House Wrap.

An example of Innovative Designs’ clothing products is its “Arctic Armor Extreme Cold Base Layer Shirt”. This shirt is 68.5 percent Thermo Cool Polyester and 31.5 percent Bamboo Charcoal. It is highly breathable and the wicking yarn keeps one comfortable and dry. It is ion-treated to promote oxygen uptake. It is also UV stable, and anti-static. The shirt also has anti-microbial technology to control odor.

Insultex® is the newest thermal insulation on the market. The material can be used in outerwear, gloves, hats, pants, tents, sleeping bags, coolers, boots, swimsuits, blankets, comforters, and other items.

Insultex® incorporates countless micro air cells. These individual pockets trap air and do not allow it to escape. This is the key to keeping people warm. Insultex® directly reflects the body’s radiant heat back to the body. Insultex® is windproof, waterproof, and buoyant.

This past June, Innovative Designs announced that it entered into a sales agreement with New Thinking Fashion USA, Inc. New Thinking Fashion USA specializes in the sale of finished fabrics to a broad assortment of apparel manufacturers. It will present Insultex™ to several of their present clients. New Thinking Fashion USA is a multilevel selling organization in the heart of the garment district on West 38th Street, New York, New York.

Also in June, Innovative Designs, in an attempt to grow its worldwide business, entered into a 2 year agreement with Epoch Consultants LLC, who has been granted exclusive rights in India. Epoch Consultants will be conducting marketing of Insultex™ to apparel manufacturers and the Indian military.

Innovative Designs, Inc. (IVDN), closed Tuesday's trading session at $0.42, up 5.00%, on 5,036 volume with 3 trades. The average volume for the last 60 days is 9,016 and the stock's 52-week low/high is $0.1256/$0.60.

Giggles N' Hugs, Inc. (GIGL)

SeriousTraders, Tip.us, RedChip, OTCJournal, StocksToBuyNow, SmallCap Network, Investor's Insight, RedChip, SmallCapVoice, and Money and Markets reported on Giggles N' Hugs, Inc. (GIGL), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Giggles N' Hugs, Inc. is the owner and operator of family-friendly restaurants. These restaurants bring together high-end, organic food with active, leading-edge play and entertainment for children. The Company features high-quality menus made from fresh and local foods. Established in 2010, Giggles N' Hugs is headquartered in Los Angeles, California. 

Each Giggles N' Hugs location offers an upscale, family-friendly atmosphere with a dedicated play area for children 10 and younger. Additionally, the Company features nightly entertainment. This includes magic shows, concerts, puppet shows, and face painting, and party packages for families. 

Membership at Giggles N' Hugs comes with benefits. These include first access to its special kids’ events, monthly deals, and unlimited visits for the whole family. The Company was voted the #1 birthday party place in Los Angeles by Nickelodeon. Moreover, it was voted "Best Pizza in Los Angeles" by Nickelodeon.

Giggles N' Hugs was also listed best family & kid-friendly restaurants by CitySearch and GoCityKids. The Company has locations in Century City, Topanga, and Glendale, California.  

Giggles N’ Hugs has engaged PacificShore Ventures to explore potential synergistic acquisition opportunities. PacificShore is an international specialty finance and Mergers & Acquisitions (M&A) firm. 

Giggles N' Hugs is targeting companies, which are cash flow positive and have minimum annual revenue of $5 million or more. PacificShore will work to identify and create target company profiles, introduce, initiate negotiations, and ultimately facilitate the closing of such potential companies and introduce traditional banking relationships for Giggles N' Hugs to finance the acquisitions. 

Giggles N’ Hugs announced in May 2017 that it signed a non-binding Letter of Intent (LOI) with City Scape trading (franchisee), a Bahrain-based hospitality company, to open up to two Giggles N’ Hugs franchise locations in Bahrain with additional locations to come if successful. With this master license agreement, Giggles N’ Hugs will receive up-front development fees for each location, and also an ongoing royalty based on a percentage of monthly gross sales.

Giggles N’ Hugs announced in June that its Global Brand Ambassador, Jillian Michaels, would launch Fitness Friday programs and introduce healthy new menu items for the Company’s locations. Jillian Michaels is a world-renowned wellness expert, business entrepreneur, and mom.

Recently, Giggles N’ Hugs announced its financial performance for Q2 ended July 2, 2017. Q2 highlights include same store Net Sales for its Glendale location increasing 4.3 percent year-over-year. Same store Net Sales for its Topanga location increased 5.0 percent year-over-year.

The Company’s Cost of Operations decreased 41.5 percent year-over-year to $429,164. Its Loss from Operations improved 46.2 percent year-over-year. The Glendale location produced record positive cash flow of more than 35 percent at the unit level.

Giggles N' Hugs, Inc. (GIGL), closed Tuesday's trading session at $0.018, up 2.27%, on 487,399 volume with 27 trades. The average volume for the last 60 days is 806,733 and the stock's 52-week low/high is $0.0018/$0.26.

graphic

The QualityStocks
Company Corner

graphic
graphic

Global Payout, Inc. (GOHE)

The QualityStocks Daily Newsletter would like to spotlight Global Payout, Inc. (GOHE). Today, Global Payout, Inc. closed trading at $0.0187, up 3.89%, on 3,873,264 volume with 59 trades. The stock’s average daily volume over the past 60 days is 2,680,616, and its 52-week low/high is $0.0077/$0.04.

Global Payout, Inc. (GOHE) is pleased to announce that its majority owned subsidiary, MoneyTrac Technology, Inc. (“MTRAC”, the “Company”) is currently in the final stages of facilitating an exclusive Joint Venture Partnership agreement (“JV”) with an established financial institution to bring effective banking solutions to businesses operating within the expanding, yet underserved, cannabis industry.

Global Payout, Inc. (GOHE) provides comprehensive payment solutions that can be fully customized for virtually any domestic and international organization distributing money worldwide. The company is committed to enabling global access to technology for optimizing financial transactions and delivering a global financial eco-system with top-tier banking institutions and the highest level financial technology partnerships.

Today, more than ever before, commercial enterprises and government institutions need powerful financial technology solutions that have the flexibility to deliver innovative customer centric services and drive operational efficiency gains throughout the organization. The Global Reserve Platform is Global Payout's fully configurable "banking-in-a-box" web-based platform that can fulfill the front-to-back office processing requirements of domestic, foreign exchange and international payment service providers. This platform is designed to improve work flow, operational efficiencies, and global financial management for enterprises operating across the globe.

The Global Reserve Platform can manage practically any financial product, including core and traditional banking products, online banking, card management, mobile wallets, merchant payment processing, biometric payments and authentication management, bill payments and P2P payments, international remittances, government benefits management, loans management, FOREX, and SWIFT / ACH / SEPA payments. Powered by the Global Reserve Administrative module, the platform can be customized for enterprises across a multitude of business sectors.

Investment in financial technology (FINTECH) companies has grown dramatically in recent years with the role of today's banks shrinking and demand for improved financial solutions continuing to rise. As the industry has continued to expand rapidly, Global Payout's management team has directed its focus on identifying the most promising market sectors with FINTECH needs. The four core areas selected are logistics, small and medium enterprises (SME), banking and travel.

In 2015, Global Payout introduced MoneyTrac Technology Inc. as a majority owned subsidiary to more effectively focus on the development of financial technologies that specifically address many of the challenges that enterprises in a variety of alternative and "high-risk" market sectors are faced with in processing financial transactions. Powered by Virtu Network Solutions, the MoneyTrac Technology platform is one the most configurable and intuitive financial technology platforms available to alternative and "high-risk" enterprises and provides them with solutions that effectively manages everything from pin debit and virtual currency, to compliance and cash flow logistics.

With the global economy constantly becoming more diversified and connected, Global Payout is well positioned with the technology software solutions its team has developed to address many different needs worldwide. Management has committed itself to exploring and identifying every avenue possible for further establishing itself as a recognized leader in FINTECH solutions. Disclaimer

Global Payout, Inc. Company Blog

Global Payout, Inc. News:

Global Payout’s MoneyTrac Technology, Inc. Enters Final Stages of Revenue-Generating Joint Venture Partnership with Established Financial Institution to Deliver Banking Solutions to the Cannabis Industry

NetworkNewsWire Announces Publication Highlighting Public Companies Creating Payment Solutions for the Cannabis Industry

Global Payout’s MoneyTrac Technology, Inc. Establishes a Revenue Sharing Joint Venture Partnership with BlazeNow Inc., an Emerging Cannabis Technology Company

PotNetwork Holdings Inc. (POTN)

The QualityStocks Daily Newsletter would like to spotlight PotNetwork Holdings Inc. (POTN). Today, PotNetwork Holdings Inc. closed trading at $0.06168, up 2.80%, on 1,525,758 volume with 121 trades. The stock’s average daily volume over the past 60 days is 4,262,112, and its 52-week low/high is $0.002/$0.0995.

PotNetwork Holding, Inc. (OTC Pink: POTN) today announces that as part of its strategy to formulate, produce and market a spectrum of exclusive and diversely targeted cannabidiol blends, the Company has appointed Dr. Michael McKenzie, industry leading physician, to the Company’s advisory board to empower management with valuable guidance, resources and insight as the Company mobilizes to serve the growing demand for premium medicinal grade products.

PotNetwork Holdings Inc. (POTN), based in Fort Lauderdale, Florida, is a holding company. The company's First Capital Venture Co. subsidiary is the owner of Diamond CBD, Inc., a producer of widely-distributed CBD hemp extracts and the primary operating entity of PotNetwork Holdings.

Diamond CBD is made up of chemists and other scientists focused on developing and producing very high-quality CBD oil over a broad range of products, based upon a thorough understanding of the various natural molecules found in hemp and their particular properties. All products are made with federally legal cannabidiol (CBD), and are available in hundreds of flavors and sizes. The company emphasizes a dedication to 100% natural lab-tested CBD ingredients, with a carefully monitored process all the way from the source farm, through production, and final delivery to retail shelves.

PotNetwork, through Diamond CBD, delivers products to all 50 states, as well as internationally, and controls 15 CBD brands. The company lists the following product brands:

  • Diamond CBD Gummies - Diamond CBD branded edible gummies made from crystal isolate. Available in a variety of flavors and gummy styles, including rainbow bites, mini fruit, gummy worms, sour snakes, and more.
  • Chill Gummies - Chill gummies are more robust than its counterpart, the "Relax" gummy line. Chill Gummies are edible CBD gummies available in a wide variety of flavors, strengths, and styles including gummy bears, sour snakes, rainbow bites, watermelon slices, sour snakes, rainbow bites, peanut butter chocolate, ocean gummies, gummy worms, gummy rings and more.
  • CBD Liquid Gold - CBD Liquid Gold is derived from naturally grown industrial hemp plants, certified by USA labs and then carefully mixed with a patent-pending (non-PG) all-natural base formulation.
  • Blue CBD - Blue CBD Crystal Isolate is a high-end vapor liquid and oral drop infused with premium CBD rich hemp oil. CBD liquids are Premium Gold quality and test at a 7X higher concentration.
  • Relax Gummies - Relax Gummies give a lighter effect of CBD with some natural flavors in comparison to its counterpart Chill Gummies. Relax Gummies are perfect for anyone with a sweet tooth that's looking for a lighter effect without sacrificing quality or taste.
  • Premium Hemp Liquid Pet - CBD For Pets is a new and refreshing product from Diamond CBD for all the millions of pets out there. It is an organic product and also has unique flavors in it.
  • CBD Re-Leaf - Disposable, long-lasting, and ready to Use CBD Re-leaf vaping pens available in a variety of flavors. Easily take CBD anywhere on the go.
  • Relax Extreme CBD - Relax Extreme CBD Oil provides a high-quality, high-strength dose of CBD through oral drops. It is very easy to use and works instantly. Simply place a drop under the tongue. Available in various strengths.
  • CBD Double Shot - CBD Double Shots are specifically designed for one-time use. Easily squeeze the package in your mouth and swallow; it's that simple. Take it anywhere you go. Relaxation is now conveniently in your pocket. Drinkable CBD shots provide a quick boost of relaxation on the go. Available in various flavors.
  • Chill Pill - CBD infused capsules available in various strengths. Relax, take a Chill Pill.

Over 1.2 million people currently use cannabis, including CBD products, for medical application, including cancer, epilepsy, and depression. By sourcing hemp outside the U.S., the company avoids current federally-based legal problems involved in growing cannabis domestically. In the meantime, PotNetwork Holdings continues to target a large and rapidly developing cannabis market, expanding from $6.5 billion in 2016, to an expected $30 billion in 2021 (Forbes), and $50 billion in 2026 (Bloomberg). The cannabidiol market alone is projected to reach $2.1 billion in 2020, a 700% increase from 2015. PotNetwork Holdings Inc. plans to expand its subsidiaries as well as make strategic acquisitions. Disclaimer

PotNetwork Holdings Inc. Company Blog

PotNetwork Holdings Inc. News:

Global Payout’s MoneyTrac Technology, Inc. Enters Final Stages of Revenue-Generating Joint Venture Partnership with Established Financial Institution to Deliver Banking Solutions to the Cannabis Industry

Continuing to Structure for Robust and Targeted Growth, PotNetwork Holding, Inc. Appoints Dr. Richard Goulding as New Chief Executive Officer

Diamond CBD to Sponsor Tommy Chong's Blazer's Cup Presented in San Bernadino in Partnership with Dank City LLC

ORHub, Inc. (ORHB)

The QualityStocks Daily Newsletter would like to spotlight ORHub, Inc. (ORHB). Today, ORHub, Inc. closed trading at $0.60, off by 1.62%, on 52,605 volume with 26 trades. The stock’s average daily volume over the past 60 days is 60,800 and its 52-week low/high is $0.20/$2.09.

ORHub, Inc. (OTC: ORHB), an advanced medical software provider focused on real-time digital delivery of case-based data analytics, today announces that Dr. Vikram Udani has joined the Company's advisory board to help lead its aggressive deployment strategy. Dr. Udani has been widely interviewed and featured on local networks, and was recently featured on FOX to discuss Senator John McCain's cancer diagnosis. To view the interview, visit: https://www.sentaclinic.com/dr-vik-udani-fox-5-discuss-senator-john-mccains-cancer-diagnosis/

ORHub, Inc. (ORHB) is a cloud-based software platform designed to transform the business of surgery into a value-based model. The platform empowers care providers at every stage of the surgical process to collaborate, organize, deliver, measure, and reimburse in one intuitive, easy-to-use program. This significantly decreases cost and improves outcomes by eliminating inefficiencies, duplications of effort, and errors and omissions that result from siloed processes in outdated software and poor handoffs from one part of the care process to another.

The need for ORHub is clear. Health care costs are out of control at more than 17% of US GDP, which equates to over $3 trillion per year. With costs rising every year due to an aging population and increasingly expensive treatments, providers are under severe pressure to become more efficient and reduce costs. This is happening because payors are aggressively reducing reimbursements and finally moving away from fee-for-service and toward a performance-based reimbursement system referred to as value-based health care.

Accurately measuring the cost of treating a condition and relating that cost to the patient's outcome is at the heart of value-based health care. Institutions that have adopted this model have reaped savings of 20-40% on their overall cost of care. Unfortunately, today's siloed IT systems are fundamentally at odds with this process. Legacy health care solutions come from a fee-for-service world and have reinforced the problem and produced a system with erratic quality and unsustainable costs. Most health care applications today are incremental improvements on these existing systems or are simple digital implementations of antiquated pen-and-paper processes.

Providers wanting to practice value-based health care need value-based software. ORHub creates a value-based solution that will revolutionize surgical care delivery by tracking the cost of treating a condition from diagnosis to discharge, and tracking outcomes that resulted from that treatment.

In an industry where major IT rollouts traditionally cost millions of dollars and take an average of eighteen months, pilot installations of ORHub have been completed in less than a month. By avoiding integration with legacy systems completely through a radically comprehensive and collaborative approach, providers see results right away. This approach produces real-time metrics in a uniform manner at any institution, which makes it ideal for large providers looking to make improvements across the board at multiple facilities.

ORHub started as a pilot program developed in cooperation with a major Southern California hospital. It has since expanded operations into a second facility at the number two non-profit hospital system in the US. Three additional pilot programs are scheduled prior to a national launch. The company has raised more than $1.6 million as of January 2017.

The company is also a showcase member of the startup program at Microsoft, which has been a key partner by providing financial assistance, strategy, introductions to influencers and mentors, and access to its sales organization who see ORHub as an exciting partner to expand the utilization of Microsoft Surface devices and Azure Cloud. Microsoft is funding a major case study in partnership with Intel about the impact of ORHub on participating institutions to be concluded sometime in Q2 2017.

ORHub's leadership team is helmed by Colt Melby, who was appointed CEO in 2016 and has been crucial to developing and executing the company's business strategy. Mr. Melby's extensive business experience includes the NASDAQ uplisting of Smith and Wesson (now American Outdoor Brands), CUI Global Inc., and Quest Resource Holdings Corp. His wealth of information and relationships have been vital in helping the company go from concept to production in institutional medicine in less than a year.

Delivering surgical care to a single patient is a complex process that may take half a dozen companies and more than a dozen departments cooperating inside and outside the care facility. ORHub simplifies and streamlines this process by enabling vendors, providers, and surgeons to collaborate on providing care. Disclaimer

ORHub, Inc. Blog

ORHub, Inc. News:

ORHub, Inc. Appoints Industry-Leading Neurosurgeon and Orthopedic Surgeon to Advisory Board

ORHub, Inc. Welcomes Internationally Recognized Spine Surgeon to its Advisory Board

ORHub, Inc. Completes over 2,000 Surgeries at Industry Leading Surgical Institution

Marijuana Company of America Inc. (MCOA)

The QualityStocks Daily Newsletter would like to spotlight Marijuana Company of America Inc. (MCOA). Today, Marijuana Company of America Inc. closed trading at $0.028, off by 0.81%, on 4,703,410 volume with 227 trades. The stock’s average daily volume over the past 60 days is 6,420,129 and its 52-week low/high is $0.0111/$0.1985.

MARIJUANA COMPANY OF AMERICA INC. ("MCOA" or the "Company") (OTC: MCOA), an innovative hemp and cannabis corporation, and Global Hemp Group (CSE: GHG) (FF: GHG) (OTC: GBHPF), (collectively the "Companies"), are pleased to announce that they have jointly entered into a letter of intent with Space Cowboys, Inc. ("Space Cowboys") for the purposes of forming a joint venture (the "Joint Venture"). Space Cowboys is an existing fully licensed and compliant hemp-derived cannabinoid producer in Colorado.

Marijuana Company of America Inc. (MCOA) (the "Company") are pioneers in the cannabis industry going back to 2009 when Don Steinberg, MCOA's CEO, founded the first marijuana company ever to trade on a US stock market, Medical Marijuana Inc. Since then, Don and his partner, Charlie Larsen, have formed Global Hemp Group and Marijuana Company of America. They have experienced the shift of legislation first hand, not only for the legalization of marijuana but also the emerging hemp-based CBD products.

The CBD market is growing expotentially and consequently the founders of MCOA have contructed their business model around the development of industrial hemp-based CBD products. The industrial hemp plant can also be used to produce products that are carbon neutral or even carbon negative, like the longest, strongest natural fiber on earth, building materials that are mold, pest and fire proof, super foods and so much more for additional business opportunities. No part of the plant is left unused and the Company's overall stategy is to take advantage of every profit center from farm to the multiple valuable finished products.

The cannabis and hemp industries are experiencing unprecedented exponential growth that is expected to continue for many years as these industries are now accepted globally and continue to mature and expand. North American consumers spent $6.7 billion on legal cannabis products in 2016, up 34% from 2015's $5 billion. This trend is widely expected to explode at a 27% compounded annual growth rate to reach $22.6 billion by 2021, according to ArcView Market Research.

The company offers investors the opportunity to be on the forefront of cannabis and hemp innovation through cultivation, processing in the legal and cannabis and industrial hemp sectors. The Company's business model includes producing a diverse portfolio of synergistic business segments that provide value to its shareholders. Its vertically integrated business model and distribution platforms are positioned to capture market share by developing recognizable and valuable brands.

Under the MCOA umbrella, wholly owned subsidiary hempSMART™, Inc. is committed to bringing high quality CBD-based products to the market through its affiliate marketing program. Through hempSMART, MCOA's strategic approach to the distribution of products is through a networking architecture geared to maintain customer loyalty and capture market share. The patent-pending product "hempSMART Brain," is designed to revolutionize the safe and effective support of healthy brain function. The brand new product, HempSMART DROPS, is a full-spectrum CBD tincture formulated with hemp and fractionated coconut oils. The hempSMART marketing team has decades of experience, and is well positioned to take the hempSMART brand to a global audience. Disclaimer

Marijuana Company of America Inc. Blog

Marijuana Company of America Inc. News:

Marijuana Company of America and Global Hemp Group to Form Joint Venture With Space Cowboys' Colorado Farm

Marijuana Company of America, Inc. (MCOA) is “One to Watch”

Marijuana Company of America and Global Hemp Group Retain Space Cowboys to Advise on Hemp Cultivation Project in New Brunswick

InMed Pharmaceuticals, Inc. (CSE:IN) (OTCQB:IMLFF)

The QualityStocks Daily Newsletter would like to spotlight InMed Pharmaceuticals, Inc. (IMLFF). Today, InMed Pharmaceuticals, Inc. closed trading at $0.3746, off by 0.90%, on 217,001 volume with 153 trades. The stock’s average daily volume over the past 60 days is 457,568, and its 52-week low/high is $0.09/$0.72.

InMed Pharmaceuticals Inc. (CSE: IN; OTCQB: IMLFF), a biopharmaceutical company specializing in the research and development of novel, cannabinoid-based drug therapies, is pleased to announce the addition of Dr. Mauro Maccarrone to its Scientific Advisory Board.

InMed Pharmaceuticals, Inc. (IMLFF) is a preclinical-stage biopharmaceutical company specializing in the development of novel therapeutics leveraging the pharmacological benefits of cannabinoids. Utilizing its proprietary bioinformatics assessment tool, InMed aims to identify bioactive compounds found within the cannabis plant that have the potential to offer optimized therapeutic benefit while demonstrating limited adverse effects. This assessment tool, in combination with the company’s cannabinoid biosynthesis technology and drug development pipeline, serves as InMed’s fundamental value driver.

Bioinformatics is a proprietary, computer-based program designed to assist in the identification of novel cannabinoids using comprehensive algorithms to integrate data from numerous bioinformatics databases, as well as a database on the structure of currently approved pharmaceutical products and an extensive database on over 90 individual cannabinoid drugs found in cannabis. This extensive collection of data is derived from both public and propriety-based sources. Leveraging this tool, the company aims to create associations between approved pharmaceuticals and cannabinoids with similar structures in order to identify active cannabinoids that have the potential to treat specific diseases. Per InMed’s website, this type of bioinformatics assessment represents “significant promise for future drug discovery, as it integrates many data sets and builds holistic models to approach a specific disease.”

After discovering these promising active cannabinoids, InMed moves to test and confirm their activity in biological systems through in vitro and in vivo experimentation. It is at this stage of development that the company’s proprietary biosynthesis process of cannabinoid manufacturing will be most promising. InMed is currently developing a robust, high-yield biosynthesis process for manufacturing all 90+ naturally-occurring cannabinoids. By modifying the agriculture-based formula for harvesting cannabinoids, InMed aims to combine the inherent safety and known efficacy of the natural drug structure with the convenience, control and quality of 21st Century laboratory-based manufacturing processes.

The company’s pipeline currently includes two drug candidates in preclinical development, including INM-750 for the treatment of epidermolysis bullosa (EB) and INM-085 for the treatment of glaucoma. Referred to by the Dystrophic Epidermolysis Bullosa Research Association of America as “The Worst Disease You’ve Never Heard Of,” EB is a rare genetic connective tissue disorder that affects roughly one out of every 20,000 births in the United States. The condition currently has no approved treatment or cure. Through the development of INM-750, InMed is attempting to address this significant unmet medical need. The drug candidate replaces missing keratins in the skin with specially selected cannabinoids in an effort to modulate the painful manifestations of EB.

INM-085, InMed’s second development candidate, is formulated to reduce the elevated intra-ocular pressure that is often associated with glaucoma. Additionally, the cannabinoids utilized in INM-085 are expected to provide neuroprotection for the retinal ganglion cells and other optic nerve tissues following topical administration. Although it is still in preclinical development, INM-085 targets a sizable market. According to the Glaucoma Research Foundation, glaucoma is a leading cause of blindness with no approved cure. The National Institutes of Health estimates that more than 3 million Americans currently have glaucoma, and more than 120,000 have been blinded by the disease.

InMed is focused on progressing toward validation of its drug candidate selection, using data to secure its patents and developing key disruptive technologies. In 2016, the company was successful in completing financings of $1.9 million. In January 2017, InMed completed a non-brokered private placement of common shares generating aggregate gross proceeds of C$1.5 million, strongly positioning the company to attract the new investment required to fund its aggressive growth strategies in 2017.

The company’s management team has well over a century of combined experience in the biopharmaceutical space. Company CEO Eric Adams has more than 25 years of experience in company and capital formation, global market development, mergers and acquisitions, licensing and corporate governance. During his time as CEO of enGene Inc., he led the gene therapy startup to a position at the head of the industry.

Joining Adams on the InMed management team are Chief Scientific Officer Dr. Sazzan Hossain; Senior Vice President, Clinical and Regulatory Affairs Alexandra D.J. Mancini; SVP, Corporate Strategy & Investor Relations Chris Bogart; and Chief Financial Officer Jeff Charpentier, as well as Chief Medical Officer Dr. Ado Muhammed, MD, DPM, MFPM.

Muhammed, in particular, has an extensive history in the pharmaceutical industry, having previously served as an executive of GW Pharmaceuticals, a global leader in the development of cannabinoid-based medicines. During his time as Associate Medical Director of that company, Muhammed played an instrumental role in the development and FDA approval of one of the first cannabis drugs. This GW Pharmaceuticals development program coincided with a sharp rise in share price from less than $9 in 2013 to more than $129 today, with the company’s current market value totaling more than $2.9 billion. Disclaimer

InMed Pharmaceuticals, Inc. Company Blog

InMed Pharmaceuticals, Inc. News:

InMed Appoints Dr. Mauro Maccarrone to its Scientific Advisory Board

InMed Pharmaceuticals Files Provisional Patent for Pain Program

NetworkNewsWire Announces Publication Highlighting Companies Engaged in Advanced Cannabinoid Research

Greenkraft, Inc. (GKIT)

The QualityStocks Daily Newsletter would like to spotlight Greenkraft, Inc. (GKIT). Today, Greenkraft, Inc. closed trading at $0.0802, off by 19.16%, on 12,550 volume with 3 trade. The stock’s average daily volume over the past 60 days is 14,768 and its 52-week low/high is $0.019/$0.20.

Greenkraft, Inc. (GKIT), a nationally recognized player in the alternative fuel engines and trucks, today announces that it is expanding its dealer network to meet increased demand for its line of alternative fuel, cab-forward trucks. Greenkraft has signed up with two additional dealers to promote and sell its commercial trucks, adding to its list of dealers.

Greenkraft, Inc. (GKIT) is a nationally recognized company specializing in the production of alternative fuel automotive products, including engines and commercial trucks. Located in Santa Ana, California, the company's mission is to provide clean, green, energy efficient automotive products that have a price advantage coupled with unparalleled American performance. Established in 2008, Greenkraft, Inc. serves the commercial truck market powered by the alternative fuels CNG and LPG in classes 4, 5, 6 and 7.

Greenkraft's new line of trucks, known as the G3 and G4, will accommodate weights of 26,000 lbs. and 33,000 lbs., respectively. George Gemayel, CEO of Greenkraft, Inc., said the demand for larger trucks that run on alternative fuels continues to increase.

"Greenkraft is going to revolutionize the trucking industry with these new 26,000 and 33,000 lbs. trucks that run on CNG and PROPANE fuel," Gemayel states in a press release. "The only way we can meet increased demand for Greenkraft products is to expand our current factory. This expansion is one of many factors that will substantially increase the Company's revenue in 2017."

Greenkraft produces a cab forward design for its commercial trucks, which allows the passenger area to be much larger than in other similar sized vehicles. Several tank capacity options exist, making it easy to select the most efficient model for a client's specific needs. Greenkraft is one of the only companies in the world to offer a refrigeration option with an alternative fuel truck – an essential, must-have option for many businesses.

Greenkraft trucks, considered among the best performing in the heavy-duty market, are used in a variety of industries and in some of the nation's largest cities. The company also offers a line of trucks designed to run with a package from Allison Transmission Holdings, Inc. (NYSE: ALSN), which gives clients the option of purchasing a fully automatic transmission vehicle. This option expands the size of the driver pool since fully automatic shifting reduces driver fatigue, contributes to solving the issue of driver retention, and it is easy to use.

CNG and LPG conversion systems made by Greenkraft are available for several major automobile brands including Ford, GM and Isuzu/GM. Installation, service, parts and warranty are all available through Greenkraft facilities and its partners. Disclaimer

Greenkraft, Inc. Blog

Greenkraft, Inc. News:

Greenkraft, Inc. Expands Distribution Network to Meet Increased Product Demand

Greenkraft, Inc. (GKIT) Engages NetworkNewsWire for Corporate Communications Solutions

NetworkNewsBreaks – Alternative Fuel Innovations Propel Greenkraft, Inc. (GKIT) to Success

graphic

Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters

graphic

1.

InvestorPlace
(ANAB) +101.17%

2.

StockMarketWatch
(KALV) +38.64%

3.

MarketClub Analysis
(HMNY) +32.24%

graphic
By The Numbers Charts
QualitystockTwits

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors
















 

The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

 

About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251